|
Disclosure of metastatic breast cancer information: Patients’ understanding and patients’ and oncologists’ experiences. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
Alexandra Garcilazo Reyes |
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
Janeth Esquivel-Gutierrez |
No Relationships to Disclose |
| |
Enrique Jose Zamudio Lozoya |
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
Haydee Cristina Verduzco-Aguirre |
Consulting or Advisory Role - Asofarma |
Travel, Accommodations, Expenses - AstraZeneca |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - AstraZeneca |
Speakers' Bureau - AstraZeneca; Lilly; Novartis |
Research Funding - Pfizer (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Gilead Sciences; Novartis |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Pfizer (Inst) |
| |
|
Honoraria - Lilly; MSD Oncology; Novartis; Pfizer |
Consulting or Advisory Role - Amplity Health; Lilly; MSD Oncology; Novartis |
Research Funding - Pfizer (Inst) |
Travel, Accommodations, Expenses - MSD Oncology; Pfizer |